Sacubitril
Sacubitril is used alongside valsartan to treat heart failure in adults. This catalogue contains one product containing sacubitril: Entresto, marketed by Novartis.
Key points
- Sacubitril belongs to a class of medicines called angiotensin receptor-neprilysin inhibitors (ARNI), which support the heart’s pumping action.
- It is combined with valsartan in the only listed product, Entresto, marketed by Novartis.
- The listed form is a tablet, with each unit containing 24 mg of sacubitril and 26 mg of valsartan.
Brands and forms in this catalogue
Entresto is the only product in this catalogue, and it combines two medicines in one tablet: sacubitril and valsartan. This means a single dose delivers both an angiotensin receptor-neprilysin inhibitor and an angiotensin receptor blocker. The combination is listed under Heart & Blood Pressure.
